PAX Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

PAX Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Sell	1,789 -424	-19%	-$72.9K	0.05%	158
2026 Q1	$374K	Hold	2,213	–	–	0.06%	146
2025 Q4	$373K	Hold	2,213	–	–	0.06%	159
2025 Q3	$319K	Sell	2,213 -579	-21%	-$79K	0.06%	177
2025 Q2	$353K	Sell	2,792 -208	-7%	-$25.5K	0.07%	174
2025 Q1	$384K	Hold	3,000	–	–	0.07%	191
2024 Q4	$397K	Hold	3,000	–	–	0.07%	188
2024 Q3	$437K	Hold	3,000	–	–	0.08%	181
2024 Q2	$412K	Hold	3,000	–	–	0.08%	187
2024 Q1	$412K	Hold	3,000	–	–	0.08%	186
2023 Q4	$403K	Hold	3,000	–	–	0.08%	183
2023 Q3	$367K	Hold	3,000	–	–	0.08%	179
2023 Q2	$381K	Hold	3,000	–	–	0.09%	172
2023 Q1	$387K	Hold	3,000	–	–	0.09%	165
2022 Q4	$394K	Hold	3,000	–	–	0.1%	149
2022 Q3	$351K	Hold	3,000	–	–	0.09%	151
2022 Q2	$353K	Hold	3,000	–	–	0.09%	146
2022 Q1	$391K	Hold	3,000	–	–	0.09%	157
2021 Q4	$458K	Hold	3,000	–	–	0.1%	141
2021 Q3	$485K	Hold	3,000	–	–	0.12%	132
2021 Q2	$491K	Hold	3,000	–	–	0.12%	126
2021 Q1	$452K	Hold	3,000	–	–	0.13%	115
2020 Q4	$454K	Hold	3,000	–	–	0.14%	100
2020 Q3	$406K	Hold	3,000	–	–	0.14%	104
2020 Q2	$410K	Hold	3,000	–	–	0.16%	89
2020 Q1	$379K	Sell	3,000 -114	-4%	-$13.1K	0.16%	85
2019 Q4	$382K	Buy	+3,114	New	+$347K	0.16%	64

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

PAX Financial Group's IBB Position: Q2 2026 in Review

PAX Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 19% in Q2 2026, selling an estimated $72.9K and leaving 1,789 shares worth $340K. The position accounts for 0.05% of the portfolio, ranked #158.

PAX Financial Group first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $491K in Q2 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

PAX Financial Group held 1,789 shares of iShares Biotechnology ETF worth $340K as of Q2 2026.
PAX Financial Group sold 424 iShares Biotechnology ETF shares in Q2 2026, an estimated $72.9K.
iShares Biotechnology ETF made up 0.05% of PAX Financial Group's portfolio in Q2 2026, its #158 holding.
PAX Financial Group first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
PAX Financial Group's iShares Biotechnology ETF position peaked at $491K in Q2 2021.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on PAX Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.